samedan logo
 
 
 
spacer
home > pmps > summer 2019 > serialising drugs to combat fraud
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Serialising Drugs to Combat Fraud

The worldwide pharmaceutical market is huge, estimated at over $1 trillion in 2016 (1). A growing portion of this is over-the-counter (OTC) medicines, which are projected to be worth $178 billion in 2024, driven by governments encouraging our ageing populations to check with their pharmacist before going to A&E to reduce the non-urgent load on hospitals (2).

An increasing number of patients are purchasing these OTC products online. Euromonitor estimates that despite only being 2% of sales in 2017, the speed at which this has grown in recent years has focused pharma companies’ attention, especially after Amazon quietly launched a line of OTC products in 2018 (3-4).

Unfortunately, buying pharmaceutical products online is fraught with issues; for example, it is estimated that a significant proportion of Viagra bought online is fake, and the side effects of counterfeit drugs can be fatal (5-6). Recently, the UK authorities seized a large amount of Diazepam, modafinil, and dermal fillers (7). The effect of poor dermal products can be life changing (8).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Gillian Ewers is an experienced marketing professional with a track record of launching new products to market in hightech businesses. She brings a wealth of knowledge of delivering strategic roadmaps, marketing materials, and product lifecycle management across multiple sectors, including semiconductors and digital inkjet printing, at companies such as Texas Instruments, Dialog, CSR, and Xaar.
spacer
Gillian Ewers
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Vetter further expands its Development Service with new site in Austria

CDMO addressing growing customer demand Investment in additional clinical filling options in Europe Planned ‘go live’ in 2021 Ravensburg, Germany and Rankweil, Austria, July 8, 2020 – With biopharmaceutical development heavily focused on specialized therapeutics, drug sponsors are increasingly turning to expert outsourcing partners to meet growing demand for complex fill and finish solutions. Vetter, a leading global Contract Development and Manufacturing Organization (CDMO) is further investing in additional capacity to meet that growing global demand with the purchase of a clinical manufacturing site located in Austria.
More info >>

White Papers

What You Need To Know About Thermal Shipping Technologies

Temptime Corporation

This paper presents highlights from a thermal performance study conducted by Modality Solutions LLC. The study examined the performance of five shipping technologies commonly used by specialty pharmacies to transport high-value refrigerated specialty medicines against an industry accepted temperature profile standard.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement